Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Impinj Inc (PI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Impinj Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B), while Impinj Inc trades at $189.45 (market cap $5.87B). The key difference: Hinge Health Inc. Class A Common Stock is the larger of the two by market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Impinj Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Impinj Inc for 22 Days on average.
| HNGE | PI | |
|---|---|---|
Market Cap | $8.47B | $5.87B |
Volume | 1,624,526 | 471,260.45 |
Sector | Health | Technology |
52-Week High | $105.14 | $241.91 |
52-Week Low | $31.17 | $91.34 |
Typical Hold Time | 0 Days | 22 Days |
Enterprise Value | $8.09B | $6.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Impinj (PI) trades at $183.26, down 3.56% today, with a bullish technical outlook supported by moving averages. The company shows strong revenue growth with $372M in 2026 but faces profitability challenges with a -7.26% net margin. Recent Q2 2026 earnings beat expectations with $0.86 EPS, and management projects strong sequential growth. Analyst sentiment remains positive with 73% buy ratings and a $178.83 consensus target.
PI offers exposure to RFID technology growth with expanding institutional interest, but investors face risks from negative profitability, high valuation multiples (P/S 15.56), and competitive pressures. The stock's near-term direction will depend on Q3 2026 results and execution against growth targets in retail and logistics markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →
